Skip to main content

BARCLAYS PLC

Position in ALT — Altimmune, Inc.

CIK 312069 LONDON, X0

Position in ALT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$594,041
-$852,106 QoQ
Shares Held
192,871
-51.9% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALT Over Time

Shares Held

Position Value (USD)

Derivatives in ALT

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$254,500
PutShares
25,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. ALT ranks #139 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $594,041 192,871
2025-12-31 $1,446,147 400,595
2025-09-30 $1,282,866 340,283
2025-06-30 $1,130,406 292,095
2025-03-31 $937,310 187,462
2024-12-31 $1,135,776 157,528
2024-09-30 $956,249 155,741
2024-06-30 $536,502 80,677
2024-03-31 $254,500 25,000
2024-03-31 $1,021,613 100,355
2023-12-31 $814,758 72,423
2023-09-30 $469,063 180,409
2023-06-30 $393,224 111,395
2023-03-31 $957,352 226,861
2022-12-31 $5,942,414 361,241
2022-09-30 $2,400,299 187,964
2022-06-30 $12,466,899 1,065,547
2022-03-31 $7,035,661 1,155,281
2021-12-31 $10,030,749 1,095,060
2021-09-30 $3,200,944 283,019
2021-06-30 $669,523 67,972
2021-03-31 $464,099 32,845
2020-12-31 $319,224 28,300
2020-09-30 $372,240 28,200
2020-06-30 $1,282,147 119,715